Home
CAPR
CAPR News

Latest Capricor Therapeutics Inc. (CAPR) News on January 22, 2025

Wall Street Analysts Believe Capricor (CAPR) Could Rally 208.09%: Here's is How to Trade

Zacks

6 days ago

Wall Street Analysts Believe Capricor (CAPR) Could Rally 208.09%: Here's is How to Trade

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Zacks

19 days ago

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

MT Newswires

20 days ago

Capricor Completes BLA Submission for Deramiocel to Treat DMD Cardiomyopathy

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire

20 days ago

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

High Growth Tech Stocks To Watch In December 2024

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In December 2024

Capricor Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

2 months ago

Capricor Therapeutics to Present at Upcoming Investor Conferences

MT Newswires

2 months ago

Capricor Gets Orphan Drug, Advanced Therapy Medicinal Product Designations for Deramiocel in Europe

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

GlobeNewswire

2 months ago

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

MT Newswires

2 months ago

JonesTrading Initiates Capricor Therapeutics at Buy Rating With $40 Price Target

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?

Insider Monkey

2 months ago

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Capricor Therapeutics Inc Earnings Call

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates

Zacks

2 months ago

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates

MT Newswires

2 months ago

Capricor Therapeutics Q3 Net Loss Widens, Revenue Declines From Year-Ago Levels

Associated Press Finance

2 months ago

Capricor: Q3 Earnings Snapshot

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

GlobeNewswire

2 months ago

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?

Zacks

2 months ago

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates

Zacks

2 months ago

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates

Verano Holdings Corp. (VRNOF) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Verano Holdings Corp. (VRNOF) Expected to Beat Earnings Estimates: Should You Buy?

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

GlobeNewswire

3 months ago

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks to Watch in October 2024

MT Newswires

3 months ago

Piper Sandler Initiates Capricor Therapeutics at Overweight With $35 Price Target

MT Newswires

3 months ago

Capricor Therapeutics Closes Underwritten Public Offering

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

3 months ago

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

MT Newswires

3 months ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

MT Newswires

3 months ago

Capricor Therapeutics Prices $75 Million Common Stock Offering

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

GlobeNewswire

3 months ago

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

MT Newswires

3 months ago

Capricor Therapeutics Starts Public Stock Offering

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

3 months ago

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

Capricor touts long-term efficacy of DMD therapy ahead of FDA application

Clinical Trials Arena

3 months ago

Capricor touts long-term efficacy of DMD therapy ahead of FDA application

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years

Benzinga

3 months ago

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years

MT Newswires

3 months ago

Capricor Reports Positive Data in Duchenne Muscular Dystrophy Study; Shares Rise

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

GlobeNewswire

3 months ago

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

Capricor Therapeutics Inc (CAPR) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com

3 months ago

Capricor Therapeutics Inc (CAPR) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

MT Newswires

3 months ago

Capricor Therapeutics Submits Biologics License Application to FDA for Duchenne Muscular Dystrophy Drug Candidate

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire

3 months ago

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?

Zacks

3 months ago

Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Capricor to Show Trial Data Over Long-Term Benefits of Deramiocel in DMD; Shares Soar

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

GlobeNewswire

4 months ago

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?

Insider Monkey

4 months ago

Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?

High Growth Tech Stocks To Watch In September 2024

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In September 2024

MT Newswires

4 months ago

Oppenheimer Adjusts Capricor Therapeutics Price Target to $43 From $15, Maintains Outperform Rating

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Cantor Fitzgerald Adjusts Capricor Therapeutics Price Target to $25 From $8, Maintains Overweight Rating; Shares Rise

MT Newswires

4 months ago

Capricor Therapeutics to Seek Full Approval of Deramiocel to Treat DMD Cardiomyopathy; Shares Rise

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

GlobeNewswire

4 months ago

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?

Zacks

4 months ago

Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

GlobeNewswire

4 months ago

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

MT Newswires

4 months ago

Oppenheimer Adjusts Capricor Therapeutics Price Target to $15 From $14, Maintains Outperform Rating

MT Newswires

4 months ago

Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire

4 months ago

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm

Benzinga

4 months ago

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

GlobeNewswire

5 months ago

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade

Simply Wall St.

5 months ago

Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade

Capricor Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Capricor Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates

Zacks

5 months ago

Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates

Associated Press Finance

5 months ago

Capricor: Q2 Earnings Snapshot

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7

GlobeNewswire

6 months ago

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7

MT Newswires

7 months ago

Capricor Therapeutics Joins Russell 3000, Russell 2000 Indexes

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

GlobeNewswire

7 months ago

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

Capricor’s cell therapy shows three year benefit in DMD patients

Clinical Trials Arena

7 months ago

Capricor’s cell therapy shows three year benefit in DMD patients

Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy

GlobeNewswire

7 months ago

Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy

CORRECTION: Capricor Therapeutics

GlobeNewswire

7 months ago

CORRECTION: Capricor Therapeutics

Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire

7 months ago

Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy

MT Newswires

7 months ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires

7 months ago

Capricor Says FDA Grants Pre-BLA Meeting Request for Duchenne Muscular Dystrophy Treatment; Shares Rise

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

7 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

7 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

7 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

7 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

7 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

7 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

7 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

7 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway

GlobeNewswire

7 months ago

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway

Capricor (CAPR) Advances in DMD Therapy With Positive Study Data

Zacks

7 months ago

Capricor (CAPR) Advances in DMD Therapy With Positive Study Data

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

7 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

7 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

7 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

7 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

7 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

7 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

7 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

7 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

US equities open lower on May jobs report

Yahoo Finance Video

7 months ago

US equities open lower on May jobs report

The Government of Canada invests over $3.3 million in nine grassroots, community projects to curb greenhouse gas emissions and fight climate change

CNW Group

7 months ago

The Government of Canada invests over $3.3 million in nine grassroots, community projects to curb greenhouse gas emissions and fight climate change

CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS

GlobeNewswire

7 months ago

CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS

GlobeNewswire

7 months ago

Onfolio Holdings Inc. To Acquire DDS Rank Business

Thor Equities Group Advances Cross-Border Logistics Strategy with Key Acquisition

GlobeNewswire

7 months ago

Thor Equities Group Advances Cross-Border Logistics Strategy with Key Acquisition

As Nvidia Teases Mega Milestone, This AI Stock Targets Early Breakout

Investor's Business Daily

7 months ago

As Nvidia Teases Mega Milestone, This AI Stock Targets Early Breakout

See's Candies® Launches New Scotchmallow® Littles

PR Newswire

7 months ago

See's Candies® Launches New Scotchmallow® Littles

Biden announces $225 mn in new aid for Ukraine at Paris talks with Zelensky

AFP

7 months ago

Biden announces $225 mn in new aid for Ukraine at Paris talks with Zelensky

Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy

GlobeNewswire

8 months ago

Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years

Simply Wall St.

8 months ago

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years

MT Newswires

8 months ago

Oppenheimer Initiates Capricor Therapeutics at Outperform Rating

GuruFocus.com

8 months ago

Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Share on Social Networks: